Pfizer Vaccine Receives FDA Approval, Paving the Way for More Vaccine Mandates


We are processing your information.

Please hold tight for a few seconds!

WE Secured
IN Financing
OWNERS national business capital logo

Pfizer Vaccine Receives FDA Approval, Paving the Way for More Vaccine Mandates

Listen To This Article

Voiced by Amazon Polly

2 min read. August 29, 2021 – by Lauren Coppolone

On Monday, the U.S. Food and Drug Administration (FDA) granted full approval to the PfizerBioNTech Covid-19 vaccine for individuals 16 and older. It’s the first coronavirus vaccine to receive full FDA approval, and many believe it will lead to additional vaccine mandates across the U.S. 

The FDA’s press release stated that going forward, the Pfizer vaccine will be marketed as Comirnaty. Acting FDA Commissioner Janet Woodcock, M.D. said, “Today’s milestone puts us one step closer to altering the course of this pandemic in the U.S.”  

Pfizer Vaccine Receives FDA Approval

How emergency use authorization works

The Pfizer vaccine has been available for emergency use for individuals ages 16 and older since December 2020. In May, the emergency use authorization was extended to children ages 12 and older. 

An emergency use authorization (EUA) grants a medical product special authorization during a health emergency. The Moderna and Johnson and Johnson vaccines are also available for emergency use, and Moderna has started applying for full approval. 

Many people see full FDA approval as an essential step to overcoming vaccine hesitancy among Americans. Just over 50% of Americans are fully vaccinated, and more than 92 million took the Pfizer vaccine. 

Officials hope that the FDA’s approval will encourage more Americans to get vaccinated. “While millions of people have already safely received COVID-19 vaccines, we recognize that for some, the FDA approval of a vaccine may now instill additional confidence to get vaccinated,” Woodcock added. 

Will FDA approval lead to additional vaccine mandates? 

White House chief medical advisor Dr. Anthony Fauci spoke to NPR, saying he believes the Pfizer vaccine approval will have a “major impact” for multiple reasons. First, roughly 20% of the U.S. population is eligible to receive the vaccine but hasn’t yet done so. 

He believes the FDA approval could encourage many of these Americans to get vaccinated. 

According to a Kaiser Family Foundation survey, 30% of unvaccinated adults said they would be more likely to get vaccinated if it had full FDA approval. 

But in addition, Dr. Fauci said that the FDA’s approval would likely encourage more companies and organizations to pass vaccine mandates. And early signs indicated that he could be right. 

Within hours of the FDA’s announcement, the Pentagon, New York City school system, and CVS announced new vaccine mandates. President Biden also urged companies in the private sector to “step up” and issue COVID-19 vaccine mandates. 

How employers can combat vaccine hesitancy

Health experts agree that a successful vaccination program is key to ending the pandemic and achieving herd immunity. And whether or not employers issue vaccine mandates, they can still play an important role in encouraging all employees to get vaccinated.

Here are proactive steps employers can take to combat vaccine hesitancy:

  • Educate employees: Companies can educate their employees about the benefits of the COVID-19 vaccines. Employers should focus on the facts, like how the Pfizer, Moderna, and Johnson and Johnson vaccines have all shown to decrease hospitalization rates by more than 99%. 
  • Provide positive rewards: For employers that don’t want to issue mandates, using rewards to encourage employees to get vaccinated can be an effective strategy. Some companies have offered gift cards and paid time off to employees that get vaccinated.

Make it easy: Getting vaccinated should be as easy as possible for all Americans. Employers can help by giving employees time off to get vaccinated, or large companies can even host on-site vaccination clinics.



BIONTECH – Covid-19

COVID-19 Vaccination – Clinical Resources for Each COVID-19 Vaccine – CDC

U.S. Food & Drug Administration – Janet Woodcock M.D.

Moderna – Covid-19 Overview

Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use

Last Updated on August 29, 2021

National Business Capital helps entrepreneurs secure quick and fair financing to save time and cultivate sustainable growth.

Our stress-free online platform is designed for simplicity and speed, helping business owners go from application to approval in a matter of hours. And while we remain a leader in the Fintech industry, our clients agree it’s our personalized service and award-winning team that sets us apart.

From SBA loans to lines of credit, to equipment financing, and more, business owners can access all the different financing programs available to them in one place. Through our streamlined process, we have helped clients secure $2 billion in financing since 2007, and, more importantly, we’ve helped entrepreneurs save a tremendous amount of time and grow faster.

About the Author, Lauren Coppolone

Lauren is the Marketing Manager at She has 7 years of professional experience with a focus on small business marketing and finance. She previously worked as a senior business analyst for B2B SaaS, Sky IT Group. She has covered topics including, business financing, startups, retail, taxes & regulations, etc. Her work has been featured by USA Today, Google & Yahoo News. Lauren holds a B.A. from the Fashion Institute of Technology’s (FIT) School of Business.

Disclaimer: The information and insights in this article are provided for informational purposes only, and do not constitute financial, legal, tax, business or personal advice from National Business Capital and the author. Do not rely on this information as advice and please consult with your financial advisor, accountant and/or attorney before making any decisions. If you rely solely on this information it is at your own risk. The information is true and accurate to the best of our knowledge, but there may be errors, omissions, or mistakes.